Arca Biopharma | ABIO - Current Assets


Arca Biopharma reported $343.86M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 31.48B 2.42B Mar/2026
Arca Biopharma USD 343.86M 11.31M Dec/2025
Biogen USD 9.19B 216.3M Mar/2026
Brainstorm Cell Therapeutics USD 307K 201K Dec/2025
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Capricor Therapeutics USD 322.94M 221.99M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 839.46M 77.51M Mar/2026
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Laboratory Of America USD 4.56B 538.3M Mar/2026
Myriad Genetics USD 332.6M 12.2M Dec/2025
Otsuka Holdings JPY 1.6T 21.76B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
United Therapeutics USD 3.7B 208.5M Dec/2025